pilipiliĀž»­

 

New chair aims to improve vaccines for children

- April 17, 2013

Dr. Joanne Langley (provided photo).
Dr. Joanne Langley (provided photo).

Dr. Joanne Langley, professor of pediatrics and community health and epidemiology at pilipiliĀž»­ Medical School, and an infectious diseases specialist at the IWK Health Centre, has been appointed pilipiliĀž»­ā€™s CIHR-GSK Chair in Pediatric Vaccinology. Itā€™s the only chair of its kind in the country.

ā€œI am honoured to have this opportunity to focus on prevention of illness, disability, and death by improving and developing vaccines and vaccine programs along with colleagues in basic science, clinical vaccine evaluation, and health policy and translation,ā€ said Dr. Langley.

As chair, Dr. Langley, a pediatrician, epidemiologist, and public health advisor to various levels of government, will aim to improve vaccines for children ā€” from the fetal period through to young adulthood. Sheā€™ll also work to prevent influenza and other respiratory infections through refined vaccine programs.

Experts believe the coming decade may well be one of unprecedented progress in vaccine innovation, development and program delivery. At pilipiliĀž»­ Medical School, more than 40 pilipiliĀž»­ investigators, all affiliated with the IWK or Capital Health, are pursuing vaccine research at Halifaxā€™s Canadian Center for Vaccinology.

ā€œOur researchers are world pioneers in child and maternal immunity, and play a leadership role in national influenza studies,ā€ said Dr. Gerry Johnston, the medical schoolā€™s associate dean of research. ā€œUniversity chair holders are at the top of their field; Dr. Langley is widely recognized as one of Canadaā€™s top vaccinology researchers.ā€

The new chair is supported by a $700,000 partnered investment from the Canadian Institutes of Health Research and GlaxoSmithKline, with additional support from Dalhousie Medical Research Foundation, Academic Pediatrics Incorporated, the Dalhousie Department of Pediatrics, the IWK Health Centre and the Canadian Center for Vaccinology.

Dr. Langleyā€™s research program will be based at the Canadian Center for Vaccinology, which is a collaborative partnership between Dalhousie, the IWK, and Capital Health.

Link: